Next, our analyses were limited to the 21 selected genes, and it is possible that if we evaluated more genes, such as BAP1, CDKN2A, FH, MEN1, MEN2, MITF, POT1, RET, SDHx, TERT, and VHL, additional cancers could be intercepted. This evidence concerns the gene MITF and cancer.